A clinical development plan (CDP) is key to bringing an investigational medicinal product (IMP) to market, as it describes the potential risks and opportunities surrounding a clinical program.

This white paper outlines key elements of a CDP, including:

• Treatment population
• Demonstration of efficacy
• Demonstration of safety
• Clinical supplies
• Timing of activities